The SEC has received an amended S-1/A registration statement from 21Shares for its proposed Injective ETF, updating the original filing submitted in October 2025. If approved, the fund would list on Nasdaq under the ticker TINJ and passively track the INJ token through the FTSE Injective Index. The proposed ETF includes a discretionary staking provision designed to enhance returns by staking a portion of its holdings. This filing represents 21Shares' expansion into the U.S. market following its previous launch of an Injective staking ETP in Europe.